These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37267224)

  • 1. Differing natural killer cell, T cell and antibody profiles in antiretroviral-naive HIV-1 viraemic controllers with and without protective HLA alleles.
    Moyano A; Ndlovu B; Mbele M; Naidoo K; Khan N; Mann JK; Ndung'u T
    PLoS One; 2023; 18(6):e0286507. PubMed ID: 37267224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
    Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
    J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers.
    Tomescu C; Duh FM; Hoh R; Viviani A; Harvill K; Martin MP; Carrington M; Deeks SG; Montaner LJ
    AIDS; 2012 Sep; 26(15):1869-78. PubMed ID: 22874514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to 'protective' human leukocyte antigen-B alleles in HIV controllers.
    French MA; Center RJ; Wilson KM; Fleyfel I; Fernandez S; Schorcht A; Stratov I; Kramski M; Kent SJ; Kelleher AD
    AIDS; 2013 Feb; 27(4):519-28. PubMed ID: 23364441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased frequencies of CD8
    Palmer CD; Romero-Tejeda M; Scully EP; Lockhart A; Seaman MS; Goldenthal A; Piechocka-Trocha A; Walker BD; Chibnik LB; Jost S; Porichis F
    J Int AIDS Soc; 2016; 19(1):21136. PubMed ID: 27938646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of NK cells is associated with HIV-1 disease progression.
    Kuri-Cervantes L; de Oca GS; Avila-Ríos S; Hernández-Juan R; Reyes-Terán G
    J Leukoc Biol; 2014 Jul; 96(1):7-16. PubMed ID: 24399837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.
    Emu B; Sinclair E; Hatano H; Ferre A; Shacklett B; Martin JN; McCune JM; Deeks SG
    J Virol; 2008 Jun; 82(11):5398-407. PubMed ID: 18353945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expansion ability but not the quality of HIV-specific CD8(+) T cells is associated with protective human leucocyte antigen class I alleles in long-term non-progressors.
    López M; Peris A; Soriano V; Lozano S; Vicario JL; Rallón NI; Restrepo C; Benito JM
    Immunology; 2011 Nov; 134(3):305-13. PubMed ID: 21978000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional advantage of educated KIR2DL1(+) natural killer cells for anti-HIV-1 antibody-dependent activation.
    Gooneratne SL; Center RJ; Kent SJ; Parsons MS
    Clin Exp Immunol; 2016 Apr; 184(1):101-9. PubMed ID: 26647083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers.
    Ferre AL; Lemongello D; Hunt PW; Morris MM; Garcia JC; Pollard RB; Yee HF; Martin JN; Deeks SG; Shacklett BL
    J Virol; 2010 Oct; 84(19):10354-65. PubMed ID: 20668079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role for HIV-specific CD38-/HLA-DR+ CD8+ T cells in viral suppression and cytotoxicity in HIV controllers.
    Hua S; Lécuroux C; Sáez-Cirión A; Pancino G; Girault I; Versmisse P; Boufassa F; Taulera O; Sinet M; Lambotte O; Venet A
    PLoS One; 2014; 9(7):e101920. PubMed ID: 25000587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses.
    Ferre AL; Hunt PW; McConnell DH; Morris MM; Garcia JC; Pollard RB; Yee HF; Martin JN; Deeks SG; Shacklett BL
    J Virol; 2010 Nov; 84(21):11020-9. PubMed ID: 20719952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-specific T-cell Responses and Generalized Activation in HIV-1 Infected Long-term Non-progressors and Progressors from South India.
    Swathirajan CR; Vignesh R; Waldrop G; Shanmugasundaram U; Nandagopal P; Solomon SS; Pradeep A; Saravanan S; Murugavel KG
    Curr HIV Res; 2018; 16(4):302-314. PubMed ID: 30543175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection.
    Long BR; Ndhlovu LC; Oksenberg JR; Lanier LL; Hecht FM; Nixon DF; Barbour JD
    J Virol; 2008 May; 82(10):4785-92. PubMed ID: 18305035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
    Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
    Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome of HIV viraemic controllers and noncontrollers with normal CD4 counts is exclusively determined by antigen-specific CD8+ T-cell-mediated HIV suppression.
    Tansiri Y; Rowland-Jones SL; Ananworanich J; Hansasuta P
    PLoS One; 2015; 10(3):e0118871. PubMed ID: 25764310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of TIGIT, PD-1 and HLA-DR/CD38 markers on CD8-T cells of children and adolescents infected with HIV and uninfected controls.
    Pereira-Manfro WF; Silva GPD; Costa PR; Costa DA; Ferreira BDS; Barreto DM; Frota ACC; Hofer CB; Kallas EG; Milagres LG
    Rev Inst Med Trop Sao Paulo; 2023; 65():e14. PubMed ID: 36753067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon Alpha Enhances NK Cell Function and the Suppressive Capacity of HIV-Specific CD8
    Kwaa AKR; Talana CAG; Blankson JN
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30404799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of CD31 expression in CD4+ and CD8+T cell subpopulations in chronic untreated HIV infection.
    Briceño O; Peralta-Prado A; Garrido-Rodríguez D; Romero-Mora K; Chávez-Torres M; de la Barrera CA; Reyes-Terán G; Ávila-Ríos S
    Immunol Lett; 2021 Jul; 235():22-31. PubMed ID: 33852965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes.
    Costa-García M; Ataya M; Moraru M; Vilches C; López-Botet M; Muntasell A
    Front Immunol; 2019; 10():687. PubMed ID: 31001281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.